Reading Time: 2 minutes CBD and anxiety – It is very likely that CBD will eventually become a treatment for anxiety (amongst other things). A study conducted by researchers at the Johns Hopkins University School of Medicine and published in the Journal of Substance Abuse Treatment asked 200 people with past-month opioid and marijuana use […]

Reading Time: 2 minutes A note on psychedelics – Before they were banned about a half-century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism and some psychiatric disorders. Researchers say it’s time for regulators, scientists, and the public to ‘revisit drugs that were once used but fell out of […]

Reading Time: < 1 minute Based on limited time, I’ve postponed top-level insights this week. I do know to acknowledge the great work the ACI is doing in the U.K. to create a CBD Safety Certification programme. I’ve previously commented on the need for standards for CBD products in emerging markets. The ACI Certification will […]

Reading Time: 3 minutes Differentiated delivery formats are still an area of uncharted territory amongst cannabis companies. There are several products in the market with minimal pharmacokinetic data to support bi-availability, yet this has not appeared to be an issue to the growing number of patients accessing cannabis. If companies want to ensure doctors […]

Reading Time: 2 minutes This week I read that overall U.S. sale of legalised cannabis was expected to reach $13.6 billion throughout 2019, up 32% from 2018’s total of $10.3 billion. I wonder if the economic slowdown which COVID-19 has created will make cannabis legalisation at the federal and state level more attractive as […]

Reading Time: 2 minutes Once again, the WHO is expecting to delay the vote affecting the scheduling of THC and CBD. At a time where CBD across the EU is under fire, a firm position from the WHO would be welcomed by the industry. However, countries have welcomed the expected postponement of the vote […]

Reading Time: 2 minutes The coronavirus outbreak in China likely will benefit American hemp companies that compete with Chinese suppliers on the global and domestic markets. And this newest issue underscores the vulnerabilities in the global marketplace that vape and other cannabis and hemp companies rely on for products ranging from LED lighting to […]

Reading Time: 2 minutes Europe offers growth opportunities for the next wave of cannabis organisations. The UK, Germany, Italy and the Netherlands already have legal systems in place for medicinal cannabis and France and Spain are currently reviewing key legislative reform to align themselves with international practices. In addition to medicinal cannabis, several key […]

Reading Time: 2 minutes Brazil and New Zealand share common fates as the two countries open up patients’ ability to access medical cannabis. Both countries emphasise GMP only products, meaning companies that intend to import into these countries require manufacture under EUGMP (or equivalent). This is however ambiguous, as the manufacturing process of cannabis […]